Back
- Former MD of Legend Capital (2004-2017), took the initiative to set up and manage the dedicated healthcare team & healthcare fund of Legend Capital (2010-2017)
- Focusing on investments in MedTech and Medical Services
- Previous investments including: Reach Surgical (M&A), Berry Genomics (SZSE: 000710), Vazyme (SHE:688105), Heng-tai (SZSE: 301370), Kangda Med (M&A), Urotronic (M&A), Wuhan Asia Heart Hospital
- EMBA, CKGSB; ME, Tsinghua University; BS, Wuhan University